Skip to main content
. 2013 Aug 20;76(1):1–8. doi: 10.1292/jvms.13-0202

Table 4. The SOD and CAT activities and the GSH and MDA levels in renal, liver, heart, spleen and lung tissues of rats with contrast-induced nephropathy (n=7).

Tissue / Parameters Experimental groups
P
Control CM Carnitine CM + Carnitine
Renal
SOD, U/mg protein 2.90 ± 0.21a,b) 2.30 ± 0.20b) 3.53 ± 0.46a) 3.16 ± 0.12a,b) *
CAT, k/mg protein 0.66 ± 0.32 0.43 ± 0.20 1.03 ± 0.52 0.71 ± 0.24 NS
GSH, mg/g protein 0.38 ± 0.02a) 0.29 ± 0.02b) 0.40 ± 0.02a) 0.38 ± 0.03a) *
MDA, nmol/mg protein 222.01 ± 19.77c) 569.54 ± 37.56a) 351.80 ± 40.18b) 426.69 ± 52.86b) ***
Liver
SOD, U/mg protein 5.49 ± 0.39a,b) 3.75 ± 0.34b) 7.22 ± 0.85a) 3.93 ± 0.22b) ***
CAT, k/mg protein 27.30 ± 8.33 17.91 ± 3.34 28.70 ± 5.59 21.66 ± 2.19 NS
GSH, mg/g protein 1.00 ± 0.14a,b) 0.38 ± 0.05c) 1.40 ± 0.22a) 0.70 ± 0.12b,c) ***
MDA, nmol/mg protein 165.35 ± 11.36a,b) 223.92 ± 22.08a) 109.41 ± 10.67b) 110.78 ± 8.17b) ***
Heart
SOD, U/mg protein 4.12 ± 0.91 2.49 ± 0.54 4.39 ± 0.65 3.71 ± 0.37 NS
CAT, k/mg protein 1.16 ± 0.74 0.37 ± 0.08 1.16 ± 0.74 1.03 ± 0.42 NS
GSH, mg/g protein 0.47 ± 0.08 0.29 ± 0.05 0.46 ± 0.11 0.42 ± 0.10 NS
MDA, nmol/mg protein 111.04 ± 17.87 136.73 ± 38.56 90.75 ± 11.42 91.11 ± 8.34 NS
Spleen
SOD, U/mg protein 4.07 ± 0.66a) 2.15 ± 0.43b) 3.65 ± 0.18a) 3.27 ± 0.20a,b) *
CAT, k/mg protein 1.39 ± 0.30a) 0.42 ± 0.06b) 1.19 ± 0.14a) 1.35 ± 0.15a) **
GSH, mg/g protein 0.64 ± 0.13b) 0.27 ± 0.02c) 1.02 ± 0.10a) 0.73 ± 0.08b) ***
MDA, nmol/mg protein 54.07 ± 6.13a) 61.82 ± 4.06a) 21.78 ± 1.93b) 52.90 ± 3.90a) ***
Lung
SOD, U/mg protein 1.31 ± 0.13 1.05 ± 0.07 1.16 ± 0.06 1.12 ± 0.03 NS
CAT, k/mg protein 0.41 ± 0.11 0.32 ± 0.14 0.51 ± 0.15 0.46 ± 0.09 NS
GSH, mg/g protein 0.45 ± 0.03a) 0.30 ± 0.04b) 0.50 ± 0.03a) 0.43 ± 0.04a) **
MDA, nmol/mg protein 25.79 ± 1.05b,c) 30.16 ± 0.53a) 24.13 ± 0.71c) 27.14 ± 0.95b) ***

a, b, c) Different letters indicate statistically significant differences in the same row. * P<0.05; ** P<0.01; *** P<0.001. NS, not significant; CM, contrast medium; CM+carnitine, contrast medium+carnitine treatment; SOD, superoxide dismutase activity; CAT, catalase; GSH, glutathione; MDA, malondialdehyde.